Follow
Gary G. Chiang
Gary G. Chiang
eFFECTOR Therapeutics
Verified email at effector.com
Title
Cited by
Cited by
Year
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson, M Liu, GG Chiang, DM Otterness, DC Loomis, F Kaper, ...
Molecular and cellular biology 22 (20), 7004-7014, 2002
15212002
Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase
GG Chiang, RT Abraham
Journal of Biological Chemistry 280 (27), 25485-25490, 2005
6652005
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
LM Lasko, CG Jakob, RP Edalji, W Qiu, D Montgomery, EL Digiammarino, ...
Nature 550 (7674), 128-132, 2017
5772017
Targeting the mTOR signaling network in cancer
GG Chiang, RT Abraham
Trends in molecular medicine 13 (10), 433-442, 2007
4282007
Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect
DA Scott, AD Richardson, FV Filipp, CA Knutzen, GG Chiang, AR Ze'ev, ...
Journal of Biological Chemistry 286 (49), 42626-42634, 2011
3942011
Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway
YW Zhang, DM Otterness, GG Chiang, W Xie, YC Liu, F Mercurio, ...
Molecular cell 19 (5), 607-618, 2005
3142005
Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells
AL Edinger, CM Linardic, GG Chiang, CB Thompson, RT Abraham
Cancer research 63 (23), 8451-8460, 2003
2182003
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
Y He, S Selvaraju, ML Curtin, CG Jakob, H Zhu, KM Comess, B Shaw, ...
Nature chemical biology 13 (4), 389-395, 2017
2052017
Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold
ZA Knight, GG Chiang, PJ Alaimo, DM Kenski, CB Ho, K Coan, ...
Bioorganic & medicinal chemistry 12 (17), 4749-4759, 2004
2052004
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
Y He, S Selvaraju, ML Curtin, CG Jakob, H Zhu, KM Comess, B Shaw, ...
Nature chemical biology 13 (4), 389-395, 2017
2042017
Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase
GG Chiang, BM Sefton
Journal of Biological Chemistry 276 (25), 23173-23178, 2001
1982001
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures
AL Howes, GG Chiang, ES Lang, CB Ho, G Powis, K Vuori, RT Abraham
Molecular cancer therapeutics 6 (9), 2505-2514, 2007
1912007
Discovery and development of potent and selective inhibitors of histone methyltransferase g9a
RF Sweis, M Pliushchev, PJ Brown, J Guo, F Li, D Maag, AM Petros, ...
ACS medicinal chemistry letters 5 (2), 205-209, 2014
1862014
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase
S Katiyar, E Liu, CA Knutzen, ES Lang, CR Lombardo, S Sankar, JI Toth, ...
EMBO reports 10 (8), 866-872, 2009
1642009
Structure-based design of pyridone–aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibition
SH Reich, PA Sprengeler, GG Chiang, JR Appleman, J Chen, J Clarine, ...
Journal of medicinal chemistry 61 (8), 3516-3540, 2018
1352018
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
KD Bromberg, TRH Mitchell, AK Upadhyay, CG Jakob, MA Jhala, ...
Nature chemical biology 13 (3), 317-324, 2017
1112017
Control of mTORC1 signaling by the Opitz syndrome protein MID1
E Liu, CA Knutzen, S Krauss, S Schweiger, GG Chiang
Proceedings of the National Academy of Sciences 108 (21), 8680-8685, 2011
1062011
Synthesis and biological evaluation of synthetic viridins derived from C (20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin
P Wipf, DJ Minion, RJ Halter, MI Berggren, CB Ho, GG Chiang, ...
Organic & biomolecular chemistry 2 (13), 1911-1920, 2004
1042004
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis
ZH Lu, MB Shvartsman, AY Lee, JM Shao, MM Murray, RD Kladney, ...
Cancer research 70 (8), 3287-3298, 2010
952010
Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor 4A RNA helicase
JT Ernst, PA Thompson, C Nilewski, PA Sprengeler, S Sperry, G Packard, ...
Journal of medicinal chemistry 63 (11), 5879-5955, 2020
942020
The system can't perform the operation now. Try again later.
Articles 1–20